ISSN 1214-0287 (on-line), ISSN 1214-021X (printed)
J Appl Biomed
Volume 11 (2013) No 1, p 33-40
DOI 10.2478/v10136-012-0018-7

Effects of insulin therapy on fracture healing and expression of VEGF in diabetic rats

Da-Wei Wang, Shun-Lei Du, Ming-Tao Xu, Yi-Ting Lu, Zhan-Chao Wang, Le-Xin Wang

Address: Le-Xin Wang, School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW 2678, Australia

Received 21st April 2012.
Revised 12th June 2012.
Published online 12th June 2012.

Full text article (pdf)
Full text article (html)

This study was designed to investigate effects of insulin on fracture healing and expression of vascular endothelial growth factor (VEGF) in diabetic rats. Wister rats were randomly divided into diabetic control (n=66), diabetic insulin (=66) and non-diabetic control group (n=66). Diabetes was established by peritoneal injection of alloxan. Tibia fracture was surgically created and was allowed to heal. Radiological and biomechanical examinations were performed on the healing tibia. Immuohistochemistry was used to assess VEGF expression in the healing fracture tissues. Cortical reconstruction of the fracture sites in non-diabetic control and diabetic insulin groups was more rapid than in diabetic control group within 6 weeks of the fracture. Mechanical strength of the affected tibia in the diabetic insulin and non-diabetic control group was superior to diabetic control group. Histological examination of the fracture sites revealed a delay in chondrocyte maturation and hypertrophy in diabetic control group. VEGF expression was widely distributed in fracture sites within the first 4 weeks in control and diabetic insulin treatment group. However VEGF expression in the callus and periosteum in diabetic control group was much less than in diabetic insulin or non-diabetic control group. In conclusion, diabetes delays fracture healing and adversely affects callus formation with a reduced VEGF expression at the fracture sites. Insulin therapy improves fracture healing in diabetes rats, possibly through enhancing VEGF expression in the fractured bones.

insulin; fracture; VEGF; diabetes; rats

Barnes GL, Kostenuik PJ, Gerstenfeld LC, Einhorn TA. Growth factor regulation of fracture repair. J Bone Miner Res. 14: 1805-1815, 1999.
[CrossRef] [PubMed]

Funk JR, Hale JE, Carmines D, Gooch HL, Hurwitz SR. Biomechanical evaluation of early fracture healing in normal and diabetic rats. J Orthopaedic Res. 18: 126-132, 2000.
[CrossRef] [PubMed]

Gandhi A, Beam HA, O'Connor JP, Parsons JR, Lin SS. The effects of local insulin delivery on diabetic fracture healing. Bone. 37: 482-490, 2005.
[CrossRef] [PubMed]

Gaston MS, Simpson AH. Inhibition of fracture healing. J Bone Joint Surg (Br). 89: 1553-1560, 2007.
[CrossRef] [PubMed]

Huh JE, Kwon NH, Baek YH, Lee JD, Choi DY, Jingushi S, Kim KI, Park DS. Formononetin promotes early fracture healing through stimulating angiogenesis by up-regulating VEGFR-2/Flk-1 in a rat fracture model. Int Immunopharmacol. 9: 1357-1365, 2009.
[CrossRef] [PubMed]

Islam MS, Loots du T. Experimental rodent models of type 2 diabetes: a review. Method Finding Exper Clin Pharmacol. 31: 249-261, 2009.

Kasahara T, Imai S, Kojima H, Katagi M, Kimura H, Chan L, Matsusue Y. Malfunction of bone marrow-derived osteoclasts and the delay of bone fracture healing in diabetic mice. Bone. 47: 617-625, 2010.
[CrossRef] [PubMed]

Kayal RA, Alblowi J, McKenzie E, Krothapalli N, Silkman L Gerstenfeld L, Einhorn TA, Graves DT. Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment. Bone. 44: 357-363, 2009.
[CrossRef] [PubMed]

Kayal RA, Siqueira M, Alblowi J, McLean J, Krothapalli N, Faibish D, Einhorn TA, Gerstenfeld LC, Graves DT. TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1. J Bone Miner Res. 25: 1604-1615, 2010.
[CrossRef] [PubMed]

Kidd LJ, Stephens AS, Kuliwaba JS, Fazzalari NL, Wu AC, Forwood MR. Temporal pattern of gene expression and histology of stress fracture healing. Bone. 46: 369-378, 2010.
[CrossRef] [PubMed]

Lee JH, Yang SH, Oh JM, Lee MG. Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus. J Pharmacy Pharmacol. 62: 1-23, 2010.
[CrossRef] [PubMed]

Lu H, Kraut D, Gerstenfeld LC, Graves DT. Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology. 144: 346-352, 2003.
[CrossRef] [PubMed]

Macey LR, Kana SM, Jingushi S, Terek RM, Borretos J, Bolander ME. Defects of early fracture-healing in experimental diabetes. J Bone Joint Surg [Am]. 71: 722-733, 1989.

Ogasawara A, Nakajima A, Nakajima F, Goto K, Yamazaki M. Molecular basis for affected cartilage formation and bone union in fracture healing of the streptozotocin-induced diabetic rat. Bone. 43: 832-839, 2008.
[CrossRef] [PubMed]

Sarahrudi K, Thomas A, Braunsteiner T, Wolf H, Vecsei V, Aharinejad S. VEGF serum concentrations in patients with long bone fractures: a comparison between impaired and normal fracture healing. J Orthopaedic Res. 27: 1293-1297, 2009.
[CrossRef] [PubMed]

Wukich DK, Joseph A, Ryan M, Ramirez C, Irrgang JJ. Outcomes of ankle fractures in patients with uncomplicated versus complicated diabetes. Foot Ankle Int. 32: 120-130, 2011.